Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
+1 212 318 2000
Europe, Middle East, & Africa
+44 20 7330 7500
+65 6212 1000
By Alex Ruoff
The Centers for Medicare & Medicaid Services is soliciting information on ways in which clinicians use clinical quality measures data reported to nonfederal programs to also report to the “meaningful use” and other Medicare programs, the agency said in a notice to be published in the Feb. 7 Federal Register.
CMS requested information on how clinicians use CQM data--such as health outcomes, patient safety reports, and clinical guidelines--reported to speciality boards, speciality societies, regional health care quality organizations, and other reporting programs to also collect data for reporting to the physician quality reporting system and the meaningful use program.
The agency said it is seeking input on how aligning the requirements of these nonfederal programs with meaningful use and the physician quality reporting system could “reduce the burden on clinicians and accelerate quality improvement.”
The physician quality reporting system is a Medicare program that uses a combination of incentive payments and payment adjustments to promote reporting of quality information by clinicians, CMS said.
CMS is asking a number of questions, including:
• How are current reporting requirements for the physician quality reporting system and reporting requirements in the meaningful use program similar to reporting requirements already established for speciality boards or to other nonfederal quality reporting programs?
• In what ways are reporting requirements for federal and nonfederal programs duplicative, and can these reporting programs be integrated to reduce reporting burdens on eligible professionals?
• Are there examples of other nonfederal programs under which clinicians report quality measures data?
Comments are due 60 days after the notice is published.
The notice to be published in the Federal Register is at http://op.bna.com/mdw.nsf/r?Open=plon-94lrtl.
Comments can be submitted at www.regulations.gov.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).